| Pharmaceutical active ingredients: |
| Charcoal ActivatedSaccharomyces Cerevisiae |
| Available forms, composition and doses of Carbolevure: |
| Capsules; Oral; Charcoal Activated 109 mg; Saccharomyces Cerevisiae 108.5 mgCapsules; Oral; Charcoal Activated 48 mg; Saccharomyces Cerevisiae 47.7 mg |
| Carbolevure medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07BA51 - Medicinal Charcoal, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pierre FabreRobapharmUCB PharmaVedim Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Formocarbine Simple | Charcoal Activated; Methenamine | GlaxoSmithKline |
| Thickhead | Charcoal Activated; Multiminerals; Multivitamins | Principle Healthare |
| Laxzyme Tablets | Charcoal Activated; Pancreatin; Simethicone | Helax Helath Care |
| Acticarbine | Charcoal Activated; Papaverine Hydrochloride | Elerte Laboratoires des Realisations Therapeutiques |
| Bicobon | Charcoal Activated; Peppermint Oil; Sodium Bicarbonate | Picharn; P P Lab |
| Carbophagix | Charcoal Activated; Saccharomyces Cerevisiae | UCB Pharma |
| Actisorb Ag+ | Charcoal Activated; Silver | Johnson & Johnson |
| Actisorb Plus | Charcoal Activated; Silver | Johnson & Johnson |
| Actisorb Silver | Charcoal Activated; Silver | Johnson & Johnson |
| Carbargal | Charcoal Activated; Simethicone | Rowe-Fleming Laboratorios |